ABVC BioPharma, Inc. (ABVC) Operating margin 2018–2025
ABVC BioPharma, Inc. (ABVC) operating margin by fiscal year — reported operating income divided by reported revenue.
-2416.0%FY2025 · since FY2018: -40031.1% → -2416.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2416.0% | -1492.6 pp |
| FY2024 | -923.3% | +3515.9 pp |
| FY2023 | -4439.2% | -2880.7 pp |
| FY2022 | -1558.5% | +1731.5 pp |
| FY2021 | -3290.1% | -1529.2 pp |
| FY2020 | -1760.9% | -1268.0 pp |
| FY2019 | -492.9% | +39538.2 pp |
| FY2018 | -40031.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ABVC financial trends
ABVC RevenueABVC Net incomeABVC Net marginABVC Gross profitABVC Gross marginABVC Operating incomeABVC Operating cash flowABVC Free cash flowABVC Capital expendituresABVC Return on equityABVC Stock buybacksABVC Dividends paidABVC Total assetsABVC Total liabilitiesABVC Shareholders’ equityABVC overview →